| 2023 |
Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas |
Articolo in rivista |
Vai |
| 2023 |
Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel |
Articolo in rivista |
Vai |
| 2023 |
HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein–Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches |
Articolo in rivista |
Vai |
| 2023 |
Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors |
Review essay (rassegna critica) |
Vai |
| 2022 |
Transcriptome and computational analysis assess the anti-tubulin activity of [1,2]oxazole derivatives in lymphoma |
Abstract in atti di convegno pubblicato in rivista |
Vai |
| 2022 |
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas |
Articolo in rivista |
Vai |
| 2022 |
GPCR Inhibition in Treating Lymphoma |
Review essay (rassegna critica) |
Vai |
